Evidence map›Paper›PMID 30416690›Full record

ArticleMediterranean journal of hematology and infectious diseases2018

The JAK2V617F Point Mutation Increases the Osteoclast Forming Ability of Monocytes in Patients with Chronic Myeloproliferative Neoplasms and Makes their Osteoclasts more Susceptible to JAK2 Inhibition.

Emmanouil Spanoudakis, Menelaos Papoutselis, Ioanna Bazdiara, Eleftheria Lamprianidi, Xrisa Kordella, Constantinos Tilkeridis, Costas Tsatalas, Ioannis Kotsianidis

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Monocyte Involvement in the Pathogenesis of Myeloproliferative Neoplasms.International journal of molecular sciences · 2025
    Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Emmanouil SpanoudakisDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Menelaos PapoutselisDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Ioanna BazdiaraDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Eleftheria LamprianidiDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Xrisa KordellaDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Constantinos TilkeridisDepartment of Orthopedics, Democritus University of Thrace, Alexandroupolis, Greece.
Costas TsatalasDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Ioannis KotsianidisDepartment of Hematology, Democritus University of Thrace, Alexandroupolis, Greece.
Democritus University of Thrace · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

JAK2V617FMyeloproliferative neoplasmOsteoclast

Identifiers

PMID30416690
PMCPMC6223546
OpenAlexW2898238495

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.